OverviewChartNewsTraderScreen

BNP Paribas Knock-Out BNTX/  DE000PC3QPU4  /

EUWAX
2024-05-16  9:50:40 PM Chg.-0.06 Bid10:00:39 PM Ask10:00:39 PM Underlying Strike price Expiration date Option type
1.19EUR -4.80% -
Bid Size: -		 -
Ask Size: -		 BioNTech SE 103.771 USD 2078-12-31 Put
GlobeNewswire 05-09 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
TeleTrader 05-06 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 05-06 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
TeleTrader 05-06 Europe mixed premarket with data on the limelight
GlobeNewswire 05-02 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 04-22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 04-10 Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire 04-07 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology
GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-27 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
TeleTrader 03-20 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 03-20 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 03-20 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
TeleTrader 03-20 Europe mixed premarket amid data
GlobeNewswire 03-14 Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire 03-12 The Gross Law Firm Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline – ...
GlobeNewswire 03-11 BNTX DEADLINE NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Co...
GlobeNewswire 03-11 FINAL DEADLINE REMINDER FOR BNTX INVESTORS: Kessler Topaz Meltzer & Check, LLP Announces Final Lead ...
GlobeNewswire 03-11 DEADLINE ALERT for DADA, BNTX, and CMI: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 03-11 BIONTECH SE (NASDAQ: BNTX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline ...
GlobeNewswire 03-11 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 03-11 BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Sub...
Newsfile Corp 03-11 BNTX DEADLINE ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioNTech SE Investors to Secure Couns...
GlobeNewswire 03-09 BIONTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit H...